Factorial Designs in Clinical Trials
3
First published: 15 July 2005

References
- 1 ACAPS Group (1992). Rationale and design for the Asymptomatic Carotid Artery Plaque Study (ACAPS), Controlled Clinical Trials 13, 293–314.
- 2 Assaf, A. R. & Carleton, R. A. (1994). The Women's Health Initiative clinical trial and observational study: history and overview, Rhode Island Medicine 77, 424–427.
- 3 ATBC Cancer Prevention Study Group (1994). The alpha-tocopherol beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance, Annals of Epidemiology 4, 1–9.
- 4 ATBC Cancer Prevention Study Group (1994). The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers, New England Journal of Medicine 330, 1029–1034.
- 5 Berson, E. L., Rosner, B., Sandberg, M. A., Hayes, K. C., Nicholson, B. W., Weigel-DiFranco, C. & Willett, W. (1993). A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa, Archives of Ophthalmology 111, 761–772.
- 6 Byar, D. P. & Piantadosi, S. (1985). Factorial designs for randomized clinical trials, Cancer Treatment Reports 69, 1055–1063.
- 7 Byar, D. P., Herzberg, A. M. & Tan, W.-Y. (1993). Incomplete factorial designs for randomized clinical trials, Statistics in Medicine 12, 1629–1641.
- 8 Cox, D. R. (1958). Planning of Experiments. Wiley, New York.
- 9 Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study (1995). A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis, Archives of Ophthalmology 113, 1479–1496.
- 10 Fisher, R. A. (1935). The Design of Experiments. Collier Macmillan, London.
- 11 Fisher, R. A. (1960). The Design of Experiments, 8th Ed. Hafner, New York.
- 12 Flather, M., Pipilis, A., Collins, R. et al. (1994). Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects, European Heart Journal 15, 608–619.
- 13 Green, A., Battistutta, D., Hart, V., Leslie, D., Marks, G., Williams, G., Gaffney, P., Parsons, P., Hirst, L., Frost, C. et al. (1994). The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: design and baseline characteristics of participants, Controlled Clinical Trials 15, 512–522.
- 14 Greenberg, E. R., Baron, J. A., Tosteson, T. D., Freeman, D. H., Jr, Beck, G. J., Bond, J. H., Colacchio, T. A., Coller, J. A., Frankl, H. D., Haile, R. W., Mandel, R. W., Nierenberg, J. S., Rothstein, D. W., Richard, S., Dale, C., Stevens, M. M., Summers, R. W. & vanStolk, R. U. (1994). A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group, New England Journal of Medicine 331, 141–147.
- 15 Heinonen, O. P., Virtamo, J., Albanes, D. et al. (1987). Beta carotene, alpha-tocopherol lung cancer intervention trial in Finland, in Proceedings of the XI Scientific Meeting of the International Epidemiologic Association, Helsinki, August, 1987. Pharmy, Helsinki.
- 16 Hennekens, C. H. & Eberlein, K. (1985). A randomized trial of aspirin and beta-carotene among U.S. physicians, Preventive Medicine 14, 165–168.
- 17 ISIS-4 Collaborative Group (1995). ISIS-4: a randomized factorial trial assessing early captopril, oral mononitrate, and intravenous magnesium-sulphate in 58 050 patients with suspected acute myocardial infarction, Lancet 345, 669–685.
- 18 Lacourciere, Y., Lefebvre, J., Poirier, L., Archambault, F. & Arnott, W. (1994). Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized double-blind, placebo-controlled, factorial-design trial, American Journal of Hypertension 7, 137–145.
- 19 Li, B., Taylor, P. R., Li, J. Y., Dawsey, S. M., Wang, W., Tangrea, J. A., Liu, B. Q., Ershow, A. G., Zheng, S. F., Fraumeni, J. F., Jr et al. (1993). Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance, Annals of Epidemiology 3, 577–585.
- 20 Lubsen, J. & Pocock, S. J. (1994). Factorial trials in cardiology (editorial), European Heart Journal 15, 585–588.
- 21 Mason, R. L. & Gunst, R. L. (1989). Statistical Design and Analysis of Experiments. Wiley, New York.
- 22 Max, M. B., Zeigler, D., Shoaf, S. E., Craig, E., Benjamin, J., Li, S. H., Buzzanell, C., Perez, M. & Ghosh, B. C. (1992). Effects of a single oral dose of desipramine on postoperative morphine analgesia, Journal of Pain & Symptom Management 7, 454–462.
- 23 Parkinson Study Group (1993). Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease, New England Journal of Medicine 328, 176–183.
- 24 Piantadosi, S. (1997). Factorial designs, in Clinical Trials: a Methodologic Perspective. Wiley, New York. See Chapter 15.
- 25 Pordy, R. C. (1994). Cilazapril plus hydrochlorothiazide: improved efficacy without reduced safety in mild to moderate hypertension. A double-blind placebo-controlled multi-center study of factorial design, Cardiology 85, 311–322.
- 26 Schellhammer, P., Shariff, R., Block, N., Soloway, M., Venner, P., Patterson, A. L., Sarosdy, M., Vogelzang, N., Jones, J. & Kiovenbag, G. (1995). A controlled trial of bicalutamide versus flutamide, each in combination with lutenizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group, Urology 45, 745–752.
- 27 Slud, E. V. (1994). Analysis of factorial survival experiments, Biometrics 50, 25–38.
- 28 Snedecor, G. W. & Cochran, W. G. (1980). Statistical Methods, 7th Ed. The Iowa State University Press, Ames.
- 29 Sperduto, R. D., Hu, T. S., Milton, R. C., Zhao, J. L., Everett, D. F., Cheng, Q. F., Blot, W. J., Bing, L., Taylor, P. R., Li, J. Y. et al. (1993). The Linxian cataract studies. Two nutrition intervention trials, Archives of Ophthalmology 111, 1246–1253.
- 30 Stampfer, M. J., Buring, J. E., Willett, W. et al. (1985). The 2 × 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians, Statistics in Medicine 4, 111–116.
- 31 Steering Committee of the Physicians' Health Study Research Group (1989). Final report on the aspirin component of the ongoing physicians' health study. New England Journal of Medicine 321, 129–135.
- 32 Thornquist, M. D., Owenn, G. S., Goodman, G. E. et al. (1993). Statistical design and monitoring of the carotene and retinol efficacy trial (CARET), Controlled Clinical Trials 14, 308–324.
- 33
Yates, F.
(1935).
Complex experiments (with discussion),
Journal of the Royal Statistical Society, Series B
2,
181–247.
10.2307/2983638 Google Scholar